Cell contact, prostaglandin E2 and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+ regulatory T cells

Clinical and Experimental Immunology - Tập 156 Số 1 - Trang 149-160 - 2009
Karen English1, Jennifer M. Ryan2, Lynda Tobin2, Mary Murphy3, Frank Barry3, Bernard P. Mahon2
1Institute of Immunology, National University of Ireland Maynooth, Maynooth, Co. Kildare, Ireland
2Institute of Immunology, National University of Ireland Maynooth, Maynooth, Co. Kildare, and
3Regenerative Medicine Institute (REMEDI), National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Ireland

Tóm tắt

SummaryAdult human mesenchymal stromal or stem cells (MSC) can differentiate into a variety of cell types and are candidate cellular therapeutics in regenerative medicine. Surprisingly, these cells also display multiple potent immunomodulatory capabilities, including allosuppression, making allogeneic cell therapy a possibility. The exact mechanisms involved in regulatory T cell induction by allogeneic human MSC was examined, using purified CD4+ populations and well-characterized bone marrow-derived adult human MSC. Allogeneic MSC were shown to induce forkhead box P3 (FoxP3)+ and CD25+ mRNA and protein expression in CD4+ T cells. This phenomenon required direct contact between MSC and purified T cells, although cell contact was not required for MSC induction of FoxP3 expression in an unseparated mononuclear cell population. In addition, through use of antagonists and neutralizing antibodies, MSC-derived prostaglandins and transforming growth factor (TGF)-β1 were shown to have a non-redundant role in the induction of CD4+CD25+FoxP3+ T cells. Purified CD4+CD25+ T cells induced by MSC co-culture expressed TGF-β1 and were able to suppress alloantigen-driven proliferative responses in mixed lymphocyte reaction. These data clarify the mechanisms of human MSC-mediated allosuppression, supporting a sequential process of regulatory T cell induction involving direct MSC contact with CD4+ cells followed by both prostaglandin E2 and TGF-β1 expression. Overall, this study provides a rational basis for ongoing clinical studies involving allogeneic MSC.

Từ khóa


Tài liệu tham khảo

Barry, 2003, Mesenchymal stem cell therapy in joint disease, Novartis Found Symp, 249, 86, 10.1002/0470867973.ch7

Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143

Friedenstein, 1966, Osteogenesis in transplants of bone marrow cells, J Embryol Exp Morphol, 16, 381

Dazzi, 2006, The role of mesenchymal stem cells in haemopoiesis, Blood Rev, 20, 161, 10.1016/j.blre.2005.11.002

Phinney, 2007, Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views, Stem Cells, 25, 2896, 10.1634/stemcells.2007-0637

Murphy, 2003, Stem cell therapy in a caprine model of osteoarthritis, Arthritis Rheum, 48, 3464, 10.1002/art.11365

Le Blanc, 2007, Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells, Leukemia, 21, 1733, 10.1038/sj.leu.2404777

Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X

Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838

Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182/blood-2002-07-2104

Glennie, 2005, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, 105, 2821, 10.1182/blood-2004-09-3696

Djouad, 2007, Mesenchymal stem cells inhibit the differentiation of dendritic cells through an Il-6-dependent mechanism, Stem Cells, 25, 2025, 10.1634/stemcells.2006-0548

Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x

Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res, 305, 33, 10.1016/j.yexcr.2004.12.013

English, 2008, Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation, Immunol Lett, 115, 50, 10.1016/j.imlet.2007.10.002

Ryan, 2005, Mesenchymal stem cells avoid allogeneic rejection, J Inflamm (Lond), 2, 8, 10.1186/1476-9255-2-8

Uccelli, 2006, Immunoregulatory function of mesenchymal stem cells, Eur J Immunol, 36, 2566, 10.1002/eji.200636416

Polchert, 2008, IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease, Eur J Immunol, 38, 1745, 10.1002/eji.200738129

English, 2007, IFN-gamma TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells, Immunol Lett, 110, 91, 10.1016/j.imlet.2007.04.001

Ryan, 2007, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clin Exp Immunol, 149, 353, 10.1111/j.1365-2249.2007.03422.x

Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559

Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, 109, 228, 10.1182/blood-2006-02-002246

Chabannes, 2007, A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells, Blood, 110, 3691, 10.1182/blood-2007-02-075481

Gieseke, 2007, Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression, Blood, 110, 2197, 10.1182/blood-2007-04-083162

Ramasamy, 2007, Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle, Transplantation, 83, 71, 10.1097/01.tp.0000244572.24780.54

Otten, 1991, Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production, Science, 251, 1228, 10.1126/science.1900952

Holt, 1989, Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance, Clin Exp Allergy, 19, 255, 10.1111/j.1365-2222.1989.tb02380.x

Maccario, 2005, Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype, Haematologica, 90, 516

Roncarolo, 2000, The role of different subsets of T regulatory cells in controlling autoimmunity, Curr Opin Immunol, 12, 676, 10.1016/S0952-7915(00)00162-X

Sakaguchi, 2008, Regulatory T cells and immune tolerance, Cell, 133, 775, 10.1016/j.cell.2008.05.009

Tang, 2008, The Foxp3+ regulatory T cell: a jack of all trades, master of regulation, Nat Immunol, 9, 239, 10.1038/ni1572

Mills, 2004, Regulatory T cells friend or foe in immunity to infection?, Nat Rev Immunol, 4, 841, 10.1038/nri1485

Baratelli, 2005, Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells, J Immunol, 175, 1483, 10.4049/jimmunol.175.3.1483

Barry, 2004, Mesenchymal stem cells: clinical applications and biological characterization, Int J Biochem Cell Biol, 36, 568, 10.1016/j.biocel.2003.11.001

Murphy, 2002, Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis, Arthritis Rheum, 46, 704, 10.1002/art.10118

Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, 8, 315, 10.1080/14653240600855905

Horwitz, 2005, Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement, Cytotherapy, 7, 393, 10.1080/14653240500319234

Fu, 2004, induces Foxp3+ T-regulatory cells from CD4+ CD25– precursors, Am J Transpl, 4, 1614, 10.1111/j.1600-6143.2004.00566.x

Barry, 2005, Immunogenicity of adult mesenchymal stem cells: lessons from the fetal allograft, Stem Cells Dev, 14, 252, 10.1089/scd.2005.14.252

Lee, 2006, Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice, Proc Natl Acad Sci USA, 103, 17438, 10.1073/pnas.0608249103

Guo, 2007, Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction, Inflammation, 30, 97, 10.1007/s10753-007-9025-3

Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7

Ringden, 2006, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease, Transplantation, 81, 1390, 10.1097/01.tp.0000214462.63943.14

Zhang, 2005, Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice, Exp Neurol, 195, 16, 10.1016/j.expneurol.2005.03.018

Augello, 2007, Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis, Arthritis Rheum, 56, 1175, 10.1002/art.22511

Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant, 30, 215, 10.1038/sj.bmt.1703650

Bang, 2005, Autologous mesenchymal stem cell transplantation in stroke patients, Ann Neurol, 57, 874, 10.1002/ana.20501

Awad, 1999, Autologous mesenchymal stem cell-mediated repair of tendon, Tissue Eng, 5, 267, 10.1089/ten.1999.5.267

Ringden, 2007, Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon, Leukemia, 21, 2271, 10.1038/sj.leu.2404833

Beyth, 2005, Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness, Blood, 105, 2214, 10.1182/blood-2004-07-2921

Chang, 2006, Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma, Stem Cells, 24, 2466, 10.1634/stemcells.2006-0071

Makwana, 2007, Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS, J Neurosci, 27, 11201, 10.1523/JNEUROSCI.2255-07.2007

Patil, 2008, Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury, Invest Ophthalmol Vis Sci, 49, 3379, 10.1167/iovs.07-1515

Peranteau, 2008, IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation, J Invest Dermatol, 128, 1852, 10.1038/sj.jid.5701232

Prevosto, 2007, Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell–lymphocyte interaction, Haematologica, 92, 881, 10.3324/haematol.11240

Selmani, 2007, HLA-G5 secretion by human mesenchymal stem cells is required to suppress T-lymphocyte and NK function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554

Croft, 1991, B cell response to fresh and effector T helper cells. Role of cognate T–B interaction and the cytokines IL-2, IL-4, and IL-6, J Immunol, 146, 4055, 10.4049/jimmunol.146.12.4055

Jiang, 2005, Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, Blood, 105, 4120, 10.1182/blood-2004-02-0586

Nauta, 2006, Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells, J Immunol, 177, 2080, 10.4049/jimmunol.177.4.2080

Zhang, 2004, Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells, Stem Cells Dev, 13, 263, 10.1089/154732804323099190

Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909

Wood, 2003, Regulatory T cells in transplantation tolerance, Nat Rev Immunol, 3, 199, 10.1038/nri1027

Bach, 2003, Regulatory T cells under scrutiny, Nat Rev Immunol, 3, 189, 10.1038/nri1026

Juedes, 2003, Using regulatory APCs to induce/maintain tolerance, Ann NY Acad Sci, 1005, 128, 10.1196/annals.1288.014

Horwitz, 2003, The role of the combination of IL-2 and TGF-beta or IL-10 in the generation and function of CD4+ CD25+ and CD8+ regulatory T cell subsets, J Leukoc Biol, 74, 471, 10.1189/jlb.0503228

Zheng, 2002, Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25– precursors, J Immunol, 169, 4183, 10.4049/jimmunol.169.8.4183

Yamagiwa, 2001, A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood, J Immunol, 166, 7282, 10.4049/jimmunol.166.12.7282

Sakaguchi, 2001, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol Rev, 182, 18, 10.1034/j.1600-065X.2001.1820102.x

Jonuleit, 2001, Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood, J Exp Med, 193, 1285, 10.1084/jem.193.11.1285

Djouad, 2003, Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals, Blood, 102, 3837, 10.1182/blood-2003-04-1193

Waldmann, 2006, Infectious tolerance and the long-term acceptance of transplanted tissue, Immunol Rev, 212, 301, 10.1111/j.0105-2896.2006.00406.x

Thông tin
Thông tin xuất bản

Clinical and Experimental Immunology

Tập 156 Số 1

149-160

Thông tin tác giả